Who
Jian Xie
President and COO
Company insider
Files Form 4 as: President and COO, Fulgent Genetics.
In numbers
- Trades disclosed
- 164
- Buys
- 0
- Sells
- 53
- Bought
- $0
- Sold
- $11.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Aug 2020
- Last trade
- 2 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 3 Sep 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $42K2,127 at $19.66 | filing |
| 2 Sep 2026filed 3 Sep 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $42K2,127 at $19.66 | filing |
| 27 Aug 2026filed 28 Aug 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $24K1,193 at $19.91 | filing |
| 27 Aug 2026filed 28 Aug 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $24K1,193 at $19.91 | filing |
| 26 Jul 2026filed 28 Jul 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $86K4,361 at $19.67 | filing |
| 26 Jul 2026filed 28 Jul 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $86K4,361 at $19.67 | filing |
| 2 Jun 2026filed 3 Jun 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $38K2,146 at $17.89 | filing |
| 2 Jun 2026filed 3 Jun 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $38K2,146 at $17.89 | filing |
| 27 May 2026filed 28 May 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $21K1,201 at $17.60 | filing |
| 27 May 2026filed 28 May 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $21K1,201 at $17.60 | filing |
| 26 Apr 2026filed 28 Apr 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $71K4,361 at $16.31 | filing |
| 26 Apr 2026filed 28 Apr 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $71K4,361 at $16.31 | filing |
| 1 Mar 2026filed 2 Mar 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $17K1,079 at $15.33 | filing |
| 1 Mar 2026filed 2 Mar 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $125K8,147 at $15.33 | filing |
| 1 Mar 2026filed 2 Mar 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $17K1,079 at $15.33 | filing |
| 1 Mar 2026filed 2 Mar 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $125K8,147 at $15.33 | filing |
| 26 Feb 2026filed 2 Mar 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $28K1,140 at $24.76 | filing |
| 26 Feb 2026filed 2 Mar 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $28K1,140 at $24.76 | filing |
| 24 Feb 2026filed 25 Feb 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —5,862 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —15,299 at $0.00 | filing |
News
Comparing Fulgent Genetics (NASDAQ:FLGT) & Agilon Health (NYSE:AGL)FLGT · themarketsdaily.com · 22 Oct 2026Analyzing Agilon Health (NYSE:AGL) and Fulgent Genetics (NASDAQ:FLGT)FLGT · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Jian Xie; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.